Properdin and C3 Proactivator: Alternate Pathway Components in Human Glomerulonephritis

Robert H. McLean; Alfred F. Michael

doi:10.1172/JCI107225

Published March 1, 1973 - More info

View PDF

Abstract

Serological and immunopathological studies of human glomerulonephritis have suggested that alternate pathways of activation of the third component of complement may be important in some forms of glomerulonephritis. We have investigated the role of two alternate pathway proteins, properdin and C3 proactivator, in 22 patients with chronic membranoproliferative glomerulonephritis, 21 patients with systemic lupus erythematosus, 20 patients with acute poststreptococcal glomerulonephritis, and 19 patients with other forms of renal disease. C3 (measured at β₁A), properdin, and C3 proactivator were assayed by single radial immunodiffusion.

In sera with low β₁A (< 2 SD), mean properdin was most significantly decreased in patients with acute poststreptococcal glomerulonephritis but was also significantly decreased in chronic membranoproliferative glomerulonephritis and in untreated systemic lupus erythematosus. Properdin levels in other renal disease, acute glomerulonephritis, and chronic membranoproliferative glomerulonephritis with normal β₁A levels were not significantly different from normal. A positive correlation between β₁A and properdin levels in individual sera was present in all diseases except systemic lupus erythematosus.

Serum C3 proactivator was markedly decreased in active systemic lupus erythematosus and there was a positive correlation between β₁A and C3 proactivator levels in systemic lupus erythematosus and other renal diseases but not acute poststreptococcal glomerulonephritis.

Properdin in fresh sera from four patients with systemic lupus erythematosus and five with chronic membranoproliferative glomerulonephritis showed increased migration toward the cathode on immunoelectrophoresis, suggesting in vivo change of the properdin molecule.

The observation of reduced serum levels of properdin and C3 proactivator and altered electrophoretic migration of properdin in some patients with glomerulonephritis provide new evidence for participation of these alternate pathway proteins in glomerulonephritis.

Images.